Xencor Inc (XNCR)
Xencor stock today
Xencor closed at $29.82 on October 30, 2026, up 2.09% on the day. Over the past year it returned +111.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.21 billion.
| Period | XNCR | S&P 500 (SPY) |
|---|---|---|
| 1 month | +19.5% | -0.9% |
| 3 months | +38.8% | +2.1% |
| Year to date | +94.8% | +11.7% |
| 1 year | +111.0% | +12.4% |
| 3 years | +73.1% | +88.5% |
| 5 years | -24.6% | +76.0% |
Key statistics
- Market value
- $2.21B
- Price / sales
- 21.1
- 52-week range
- $10.41 to $29.99
- Next report
- Nov 4, 2026 (estimated)
About Xencor
Develops monoclonal antibody therapeutics for oncology and other diseases.
Sector: Health Care
More on Xencor
- Financials: revenue, earnings and segmentsRevenue +14% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $1,441 today
No forecast, no recommendation. This page describes Xencor Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.